EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 26 srpnja 2024. Database contains 4821 unique substances/entries.
Filter the list
|
A complex combination of hydrocarbons produced by the atmospheric distillation of a butane-butylene stream. It consists of aliphatic hydrocarbons having carbon numbers predominantly in the range of C3 through C4.
|
270-769-7
|
68477-87-2
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
||
|
A complex high octane combination of hydrocarbons obtained by the catalytic dehydrogenation of a predominantly naphthenic naphtha. It consists predominantly of aromatics and non-aromatics having carbon numbers predominantly in the range of C5 through C11 and boiling in the range of approximately 45°C to 185°C (113°F to 365°F).
|
297-458-9
|
93572-29-3
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons separated from natural gas by processes such as refrigeration or absorption. It consists predominantly of saturated aliphatic hydrocarbons having carbon numbers predominantly in the range of C4 through C8 and boiling in the range of approximately minus 20°C to 120°C (-4°F to 248°F).
|
232-349-1
|
8006-61-9
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons obtained from the fractionation of depropanizer bottoms. It consists of hydrocarbons having carbon numbers predominantly greater than C5.
|
271-726-5
|
68606-10-0
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons produced from the topping plant by the distillation of crude oil. It boils in the range of approximately 36.1°C to 193.3°C (97°F to 380°F).
|
271-727-0
|
68606-11-1
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons separated from the gases from vapor recovery systems by cooling. It consists of hydrocarbons having carbon numbers predominantly in the range of C4 through C11 and boiling in the range of approximately -20°C to 196°C(-4°F to 384°F).
|
271-025-4
|
68514-15-8
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons consisting primarily of paraffins, cycloparaffins, aromatic and olefinic hydrocarbons having carbon numbers predominantly greater than C3 and boiling in the range of 30°C to 260°C (86°F to 500°F).
|
289-220-8
|
86290-81-5
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
203-377-1
|
106-24-1
|
Skin Sens. 1 |
|||
|
232-589-7
|
9001-22-3
|
Resp. Sens. 1 |
|||
|
278-636-5
|
77182-82-2
|
Repr. 1B; Acute Tox. 4; STOT RE 2 |
|||
|
203-856-5
|
111-30-8
|
Acute Tox. 2; Acute Tox. 3; STOT SE 3; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1A |
yes |
||
|
200-240-8
|
55-63-0
|
Expl. 1.1; Acute Tox. 2; Acute Tox. 1; STOT RE 2 |
|||
|
200-240-8
|
55-63-0
|
Unst. Expl.; Acute Tox. 2; Acute Tox. 1; STOT RE 2 |
|||
|
203-474-9
|
107-22-2
|
Muta. 2; Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
|||
|
206-058-5
|
298-12-4
|
Eye Dam. 1; Skin Sens. 1B |
|||
|
213-997-4
|
1071-83-6
|
Eye Dam. 1 |
|||
|
219-468-4
|
2439-99-8
|
Eye Dam. 1 |
|||
|
201-964-7
|
90-05-1
|
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
|||
|
200-002-3
|
50-01-1
|
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
|||
|
218-165-4
|
2058-94-8
|
yes |
|||
|
200-962-3
|
76-44-8
|
Carc. 2; Acute Tox. 3; STOT RE 2 |
|||
|
213-831-0
|
1024-57-3
|
Carc. 2; Acute Tox. 3; STOT RE 2 |
|||
|
206-803-4
|
376-06-7
|
yes |
|||
|
203-767-1
|
110-43-0
|
Flam. Liq. 3; Acute Tox. 4 |
|||
|
203-388-1
|
106-35-4
|
Flam. Liq. 3; Acute Tox. 4; Eye Irrit. 2 |
|||
|
204-608-9
|
123-19-3
|
Flam. Liq. 3; Acute Tox. 4 |
|||
|
205-563-8
|
142-82-5
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
203-838-7
|
111-14-8
|
Skin Corr. 1B |
|||
|
245-737-0
|
23560-59-0
|
Acute Tox. 3 |
|||
|
show/hide
|
247-148-4
|
25637-99-4
|
Repr. 2; Lact. |
yes |
|
|
204-129-5
|
116-16-5
|
Acute Tox. 4 |
|||
|
204-273-9
|
118-74-1
|
Carc. 1B; STOT RE 1 |
|||
|
201-029-3
|
77-47-4
|
Acute Tox. 2; Acute Tox. 3; Acute Tox. 4; Skin Corr. 1B |
|||
|
241-010-7
|
16941-12-1
|
Acute Tox. 3; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 |
|||
|
204-127-4
|
116-15-4
|
Press. Gas; Acute Tox. 4; STOT SE 3 |
|||
|
256-356-4
|
48122-14-1
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
260-566-1
|
57110-29-9
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
243-072-0
|
19438-60-9
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
247-094-1
|
25550-51-0
|
Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
235-921-9
|
13048-33-4
|
Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 |
|||
|
212-485-8
|
822-06-0
|
Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
|||
|
204-679-6
|
124-09-4
|
Acute Tox. 4; STOT SE 3; Skin Corr. 1B |
|||
|
211-653-8
|
680-31-9
|
Carc. 1B; Muta. 1B |
|||
|
203-852-3
|
111-27-3
|
Acute Tox. 4 |
|||
|
209-731-1
|
591-78-6
|
Flam. Liq. 3; Repr. 2; STOT RE 1; STOT SE 3 |
|||
|
203-523-4
|
107-83-5
|
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3 |
|||
|
247-143-7
|
25637-27-8
|
Acute Tox. 4 |
|||
|
257-074-4
|
51235-04-2
|
Acute Tox. 4; Eye Irrit. 2 |
|||
|
219-698-5
|
2499-95-8
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
|||
|
206-114-9
|
302-01-2
|
Flam. Liq. 3; Carc. 1B; Acute Tox. 3; Skin Corr. 1B; Skin Sens. 1 |
yes |
||